| Stem cell factor and its receptor c-Kit as targets for inflammatory diseases L Reber, CA Da Silva, N Frossard European journal of pharmacology 533 (1-3), 327-340, 2006 | 352 | 2006 |
| Neurogenic mechanisms in bronchial inflammatory diseases DA Groneberg, D Quarcoo, N Frossard, A Fischer Allergy 59 (11), 1139-1152, 2004 | 292 | 2004 |
| The nerve growth factor and its receptors in airway inflammatory diseases V Freund-Michel, N Frossard Pharmacology & therapeutics 117 (1), 52-76, 2008 | 247 | 2008 |
| Transforming growth factor-β and its role in asthma C Duvernelle, V Freund, N Frossard Pulmonary pharmacology & therapeutics 16 (4), 181-196, 2003 | 221 | 2003 |
| Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma Z Zhang, P Hener, N Frossard, S Kato, D Metzger, M Li, P Chambon Proceedings of the National Academy of Sciences 106 (5), 1536-1541, 2009 | 219 | 2009 |
| Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation L Reber, L Vermeulen, G Haegeman, N Frossard PloS one 4 (2), e4393, 2009 | 203 | 2009 |
| Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. N Frossard, KJ Rhoden, PJ Barnes The Journal of pharmacology and experimental therapeutics 248 (1), 292-298, 1989 | 190 | 1989 |
| Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low‐dose O Kassel, F De Blay, C Duvernelle, C Olgart, D Israel‐Biet, P Krieger, ... Clinical & Experimental Allergy 31 (9), 1432-1440, 2001 | 170 | 2001 |
| Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Y Amrani, RA Panettieri Jr, N Frossard, C Bronner American journal of respiratory cell and molecular biology 15 (1), 55-63, 1996 | 170 | 1996 |
| Nerve growth factor and its receptors in asthma and inflammation N Frossard, V Freund, C Advenier European journal of pharmacology 500 (1-3), 453-465, 2004 | 156 | 2004 |
| Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? J Becker, C Delayre‐Orthez, N Frossard, F Pons Fundamental & clinical pharmacology 20 (5), 429-447, 2006 | 151 | 2006 |
| Nerve growth factor levels and localisation in human asthmatic bronchi CO Höglund, F De Blay, JP Oster, C Duvernelle, O Kassel, G Pauli, ... European Respiratory Journal 20 (5), 1110-1116, 2002 | 150 | 2002 |
| New insights into the second generation antihistamines GM Walsh, L Annunziato, N Frossard, K Knol, S Levander, JM Nicolas, ... Drugs 61, 207-236, 2001 | 144 | 2001 |
| Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids C Olgart, N Frossard European Respiratory Journal 18 (1), 115-121, 2001 | 137 | 2001 |
| Small neutralizing molecules to inhibit actions of the chemokine CXCL12 M Hachet-Haas, K Balabanian, F Rohmer, F Pons, C Franchet, S Lecat, ... Journal of Biological Chemistry 283 (34), 23189-23199, 2008 | 128 | 2008 |
| Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. E Tschirhart, N Frossard, C Bertrand, Y Landry Journal of Pharmacology and Experimental Therapeutics 243 (1), 310-316, 1987 | 118 | 1987 |
| PPARα downregulates airway inflammation induced by lipopolysaccharide in the mouse C Delayre-Orthez, J Becker, I Guenon, V Lagente, J Auwerx, N Frossard, ... Respiratory research 6, 1-10, 2005 | 116 | 2005 |
| Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions V Freund, F Pons, V Joly, E Mathieu, N Martinet, N Frossard European Respiratory Journal 20 (2), 458-463, 2002 | 114 | 2002 |
| Clinical and Inflammatory Responses to Exogenous Tachykinins in Allergic Rhinitis1-3 G Braunstein, I Fajac, J Lacronique, N Frossard Am Rev Respir Dis 144, 630-635, 1991 | 113 | 1991 |
| Towards targeting resolution pathways of airway inflammation in asthma C Barnig, N Frossard, BD Levy Pharmacology & therapeutics 186, 98-113, 2018 | 111 | 2018 |
